Xing Zhang
- Cancer Research top 2%
- Cancer-related molecular mechanisms research 5
- Immunology top 5%
- interferon and immune responses 4
- Immune Cell Function and Interaction 4
- Molecular Biology top 5%
- Renal and related cancers 5
- RNA modifications and cancer 4
- Epigenetics and DNA Methylation 4
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers 5
- Nephrology top 10%
-
- Lung Cancer Treatments and Mutations 4
- Journals
- Nucleic Acids Research (2 papers)Journal of Biological Chemistry (1 paper)Nature Communications (1 paper)
- Partner nations
- ChinaUnited StatesSingapore
In The Last Decade
Xing Zhang
106 papers receiving 2.6k citations
Hit Papers
Peers
Comparison fields: 5 of 125
- Cancer Research 747
- Immunology 522
- Molecular Biology 1.5k
- Oncology 307
- Nephrology 70
Countries citing papers authored by Xing Zhang
This map shows the geographic impact of Xing Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xing Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xing Zhang more than expected).
Fields of papers citing papers by Xing Zhang
This network shows the impact of papers produced by Xing Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xing Zhang. The network helps show where Xing Zhang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xing Zhang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 3 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 4 | |
| 8 | 2023 | 16 | |
| 9 | 2023 | 1 | |
| 10 | 2023 | 2 | |
| 11 | 2023 | 5 | |
| 12 | 2022 | 18 | |
| 13 | 2021 | 3 | |
| 14 | 2020 | 21 | |
| 15 | 2019 | 47 | |
| 16 | GTS-21 attenuates LPS-induced renal injury via the cholinergic anti-inflammatory pathway in mice. | 2017 | 11 |
| 17 | 2017 | 34 | |
| 18 | Expression and clinical significance of high mobility group box 1 in stage IIIB colon cancer | 2011 | 1 |
| 19 | 2011 | 1 | |
| 20 | 2011 | 20 |
About Xing Zhang
Xing Zhang is a scholar working on Transplantation, Family Practice and Immunology, having authored 114 papers that have together received 2.7k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (5 papers), Cancer-related molecular mechanisms research (5 papers), Renal and related cancers (5 papers), interferon and immune responses (4 papers), Immune Cell Function and Interaction (4 papers), RNA modifications and cancer (4 papers), Lung Cancer Treatments and Mutations (4 papers) and Epigenetics and DNA Methylation (4 papers). The work is most often cited by research in Cancer Research (747 citations), Immunology (522 citations) and Molecular Biology (1.5k citations). Xing Zhang has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Sen Wang, Guangli Sun, Zheng Chen, Haixiao Wang, Penghui Xu, Zekuan Xu, Jialun Lv, Jiacheng Cao, Jianghao Xu and Xiaoxu Huang. Their work appears in journals such as Nucleic Acids Research, Journal of Biological Chemistry and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.